Related Experiment Videos
Cross-reactive antibodies induced by a monovalent influenza B virus vaccine
R A Levandowski1, P A Gross, M Weksler
1Division of Virology, Center for Biologics Evaluation and Research, Bethesda, Maryland 20892.
Journal of Clinical Microbiology
|July 1, 1991
Abstract:
Influenza viruses related to the markedly antigenically divergent strains B/Yamagata/16/88 and B/Victoria/2/87 are circulating in human populations. Adults develop cross-reacting antibodies against recent and earlier influenza B virus strains after vaccination with B/Yamagata/16/88, probably because of previous influenza B virus infections or immunizations. Vaccines containing B/Yamagata/16/88 should adequately protect adults against B/Victoria/2/87 infections.